Home

PARTERS VII L P DOMAIN

CIK 1374150 · last filed 2014-03-21

PARTERS VII L P DOMAIN is a corporate insider who has filed 20 SEC Form 4 insider transactions across 7 companies since 2008. Across all open-market trades the lifetime net is +$48.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $11.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.45M

Companies

7

Total Filings

20

Lifetime Open-Market Net

$48.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Achaogen, Inc. (AKAO) Delisted 10%+ Owner 1,987,049 — — $0 1 2014-03-17
TNDM 10%+ Owner 318,906 $18.10 $5.77M $0 1 2013-11-19
Evoke Pharma Inc (OMED) Delisted 10%+ Owner 1,114,327 — — $0 1 2013-09-30
ESPR 10%+ Owner 1,786,012 $3.18 $5.68M $3.93M 1 2013-07-02
Orexigen Therapeutics, Inc. (OREX) Delisted 10%+ Owner 296,742 — — $16.89M 12 2011-12-22
Clovis Oncology, Inc. (CLVS) Delisted 10%+ Owner 1,704,080 $0.08 $138.4K $11.91M 1 2011-11-21
ZOGENIX, INC. (ZGNX) Delisted 10%+ Owner 1,240,417 $26.68 $33.09M $16.12M 2 2011-09-20

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-03-21 — Disp (D) −2,972,678 -$41.62M
2014-03-17 Achaogen, Inc. (AKAO) Delisted Conv (C) +1,987,049 $0 EDGAR
2013-11-19 TNDM Mixed +3,189,058 $0 EDGAR
2013-09-30 Evoke Pharma Inc (OMED) Delisted Conv (C) +1,114,327 $0 EDGAR
2013-07-02 ESPR Mixed +2,066,935 $3.93M EDGAR
2011-12-22 Orexigen Therapeutics, Inc. (OREX) Delisted Buy (P) +461,265 $668.8K EDGAR
2011-11-21 Clovis Oncology, Inc. (CLVS) Delisted Mixed +2,990,937 $11.91M EDGAR
2011-09-20 ZOGENIX, INC. (ZGNX) Delisted Buy (P) +3,441,304 $6.88M EDGAR
2010-12-01 ZOGENIX, INC. (ZGNX) Delisted Mixed +6,482,031 $9.24M EDGAR
2009-12-21 Orexigen Therapeutics, Inc. (OREX) Delisted Buy (P) +135,784 $1.02M EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.